Selected research
Market Analysis & Forecast
Global Cell Activity Assay Service Market Analysis and Forecast 2026-2032
Market perspective
The global Cell Activity Assay Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Cell Activity Assay Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Cell Activity Assay Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Cell Activity Assay Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Cell Activity Assay Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Cell Activity Assay Service include Promab Biotechnologies, IBR Inc, Multispan, Promega, Domainex, BioAgilytix, Charles River Laboratories, MD Biosciences and Creative Bioarray, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Cell Activity Assay Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Cell Activity Assay Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Cell Activity Assay Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cell Activity Assay Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cell Activity Assay Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cell Activity Assay Service revenue, projected growth trends, production technology, application and end-user industry.
Cell Activity Assay Service Segment by Company
Promab Biotechnologies
IBR Inc
Multispan
Promega
Domainex
BioAgilytix
Charles River Laboratories
MD Biosciences
Creative Bioarray
STEMCELL Technologies
Lonza Bioscience
Merck KGaA
Thermo Fisher Scientific
MarinBio
Visikol
Malvern Panalytical
SGS
Innoprot
Vela Labs GmbH
Hanugen Theraputics
Cell Activity Assay Service Segment by Type
ATP Content Determination Method
Fluorescent Staining Method
Colorimetric Method
Other
Cell Activity Assay Service Segment by Application
Biopharmaceutical and Biotechnology Companies
Research Institutes
Cell Activity Assay Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Activity Assay Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell Activity Assay Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Activity Assay Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Cell Activity Assay Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Cell Activity Assay Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Activity Assay Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- ATP Content Determination Method
- Fluorescent Staining Method
- Colorimetric Method
- Other
Applications
- Biopharmaceutical and Biotechnology Companies
- Research Institutes
Companies covered
- Promab Biotechnologies
- IBR Inc
- Multispan
- Promega
- Domainex
- BioAgilytix
- Charles River Laboratories
- MD Biosciences
- Creative Bioarray
- STEMCELL Technologies
- Lonza Bioscience
- Merck KGaA
- Thermo Fisher Scientific
- MarinBio
- Visikol
- Malvern Panalytical
- SGS
- Innoprot
- Vela Labs GmbH
- Hanugen Theraputics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Cell Activity Assay Service Market by Type
- 1.2.1 Global Cell Activity Assay Service Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 ATP Content Determination Method
- 1.2.3 Fluorescent Staining Method
- 1.2.4 Colorimetric Method
- 1.2.5 Other
- 1.3 Cell Activity Assay Service Market by Application
- 1.3.1 Global Cell Activity Assay Service Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Biopharmaceutical and Biotechnology Companies
- 1.3.3 Research Institutes
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Cell Activity Assay Service Market Dynamics
- 2.1 Cell Activity Assay Service Industry Trends
- 2.2 Cell Activity Assay Service Industry Drivers
- 2.3 Cell Activity Assay Service Industry Opportunities and Challenges
- 2.4 Cell Activity Assay Service Industry Restraints
3 Global Growth Perspective
- 3.1 Global Cell Activity Assay Service Market Perspective (2021-2032)
- 3.2 Global Cell Activity Assay Service Growth Trends by Region
- 3.2.1 Global Cell Activity Assay Service Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Cell Activity Assay Service Market Size by Region (2021-2026)
- 3.2.3 Global Cell Activity Assay Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Cell Activity Assay Service Revenue by Players
- 4.1.1 Global Cell Activity Assay Service Revenue by Players (2021-2026)
- 4.1.2 Global Cell Activity Assay Service Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Cell Activity Assay Service Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Cell Activity Assay Service Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Cell Activity Assay Service Key Players Headquarters & Area Served
- 4.4 Global Cell Activity Assay Service Players, Product Type & Application
- 4.5 Global Cell Activity Assay Service Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Cell Activity Assay Service Market CR5 and HHI
- 4.6.3 2025 Cell Activity Assay Service Tier 1, Tier 2, and Tier 3
5 Cell Activity Assay Service Market Size by Type
- 5.1 Global Cell Activity Assay Service Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Cell Activity Assay Service Revenue by Type (2021-2032)
- 5.3 Global Cell Activity Assay Service Revenue Market Share by Type (2021-2032)
6 Cell Activity Assay Service Market Size by Application
- 6.1 Global Cell Activity Assay Service Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Cell Activity Assay Service Revenue by Application (2021-2032)
- 6.3 Global Cell Activity Assay Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Promab Biotechnologies
- 7.1.1 Promab Biotechnologies Company Information
- 7.1.2 Promab Biotechnologies Business Overview
- 7.1.3 Promab Biotechnologies Cell Activity Assay Service Revenue and Gross Margin (2021-2026)
- 7.1.4 Promab Biotechnologies Cell Activity Assay Service Product Portfolio
- 7.1.5 Promab Biotechnologies Recent Developments
- 7.2 IBR Inc
- 7.2.1 IBR Inc Company Information
- 7.2.2 IBR Inc Business Overview
- 7.2.3 IBR Inc Cell Activity Assay Service Revenue and Gross Margin (2021-2026)
- 7.2.4 IBR Inc Cell Activity Assay Service Product Portfolio
- 7.2.5 IBR Inc Recent Developments
- 7.3 Multispan
- 7.3.1 Multispan Company Information
- 7.3.2 Multispan Business Overview
- 7.3.3 Multispan Cell Activity Assay Service Revenue and Gross Margin (2021-2026)
- 7.3.4 Multispan Cell Activity Assay Service Product Portfolio
- 7.3.5 Multispan Recent Developments
- 7.4 Promega
- 7.4.1 Promega Company Information
- 7.4.2 Promega Business Overview
- 7.4.3 Promega Cell Activity Assay Service Revenue and Gross Margin (2021-2026)
- 7.4.4 Promega Cell Activity Assay Service Product Portfolio
- 7.4.5 Promega Recent Developments
- 7.5 Domainex
- 7.5.1 Domainex Company Information
- 7.5.2 Domainex Business Overview
- 7.5.3 Domainex Cell Activity Assay Service Revenue and Gross Margin (2021-2026)
- 7.5.4 Domainex Cell Activity Assay Service Product Portfolio
- 7.5.5 Domainex Recent Developments
- 7.6 BioAgilytix
- 7.6.1 BioAgilytix Company Information
- 7.6.2 BioAgilytix Business Overview
- 7.6.3 BioAgilytix Cell Activity Assay Service Revenue and Gross Margin (2021-2026)
- 7.6.4 BioAgilytix Cell Activity Assay Service Product Portfolio
- 7.6.5 BioAgilytix Recent Developments
- 7.7 Charles River Laboratories
- 7.7.1 Charles River Laboratories Company Information
- 7.7.2 Charles River Laboratories Business Overview
- 7.7.3 Charles River Laboratories Cell Activity Assay Service Revenue and Gross Margin (2021-2026)
- 7.7.4 Charles River Laboratories Cell Activity Assay Service Product Portfolio
- 7.7.5 Charles River Laboratories Recent Developments
- 7.8 MD Biosciences
- 7.8.1 MD Biosciences Company Information
- 7.8.2 MD Biosciences Business Overview
- 7.8.3 MD Biosciences Cell Activity Assay Service Revenue and Gross Margin (2021-2026)
- 7.8.4 MD Biosciences Cell Activity Assay Service Product Portfolio
- 7.8.5 MD Biosciences Recent Developments
- 7.9 Creative Bioarray
- 7.9.1 Creative Bioarray Company Information
- 7.9.2 Creative Bioarray Business Overview
- 7.9.3 Creative Bioarray Cell Activity Assay Service Revenue and Gross Margin (2021-2026)
- 7.9.4 Creative Bioarray Cell Activity Assay Service Product Portfolio
- 7.9.5 Creative Bioarray Recent Developments
- 7.10 STEMCELL Technologies
- 7.10.1 STEMCELL Technologies Company Information
- 7.10.2 STEMCELL Technologies Business Overview
- 7.10.3 STEMCELL Technologies Cell Activity Assay Service Revenue and Gross Margin (2021-2026)
- 7.10.4 STEMCELL Technologies Cell Activity Assay Service Product Portfolio
- 7.10.5 STEMCELL Technologies Recent Developments
- 7.11 Lonza Bioscience
- 7.11.1 Lonza Bioscience Company Information
- 7.11.2 Lonza Bioscience Business Overview
- 7.11.3 Lonza Bioscience Cell Activity Assay Service Revenue and Gross Margin (2021-2026)
- 7.11.4 Lonza Bioscience Cell Activity Assay Service Product Portfolio
- 7.11.5 Lonza Bioscience Recent Developments
- 7.12 Merck KGaA
- 7.12.1 Merck KGaA Company Information
- 7.12.2 Merck KGaA Business Overview
- 7.12.3 Merck KGaA Cell Activity Assay Service Revenue and Gross Margin (2021-2026)
- 7.12.4 Merck KGaA Cell Activity Assay Service Product Portfolio
- 7.12.5 Merck KGaA Recent Developments
- 7.13 Thermo Fisher Scientific
- 7.13.1 Thermo Fisher Scientific Company Information
- 7.13.2 Thermo Fisher Scientific Business Overview
- 7.13.3 Thermo Fisher Scientific Cell Activity Assay Service Revenue and Gross Margin (2021-2026)
- 7.13.4 Thermo Fisher Scientific Cell Activity Assay Service Product Portfolio
- 7.13.5 Thermo Fisher Scientific Recent Developments
- 7.14 MarinBio
- 7.14.1 MarinBio Company Information
- 7.14.2 MarinBio Business Overview
- 7.14.3 MarinBio Cell Activity Assay Service Revenue and Gross Margin (2021-2026)
- 7.14.4 MarinBio Cell Activity Assay Service Product Portfolio
- 7.14.5 MarinBio Recent Developments
- 7.15 Visikol
- 7.15.1 Visikol Company Information
- 7.15.2 Visikol Business Overview
- 7.15.3 Visikol Cell Activity Assay Service Revenue and Gross Margin (2021-2026)
- 7.15.4 Visikol Cell Activity Assay Service Product Portfolio
- 7.15.5 Visikol Recent Developments
- 7.16 Malvern Panalytical
- 7.16.1 Malvern Panalytical Company Information
- 7.16.2 Malvern Panalytical Business Overview
- 7.16.3 Malvern Panalytical Cell Activity Assay Service Revenue and Gross Margin (2021-2026)
- 7.16.4 Malvern Panalytical Cell Activity Assay Service Product Portfolio
- 7.16.5 Malvern Panalytical Recent Developments
- 7.17 SGS
- 7.17.1 SGS Company Information
- 7.17.2 SGS Business Overview
- 7.17.3 SGS Cell Activity Assay Service Revenue and Gross Margin (2021-2026)
- 7.17.4 SGS Cell Activity Assay Service Product Portfolio
- 7.17.5 SGS Recent Developments
- 7.18 Innoprot
- 7.18.1 Innoprot Company Information
- 7.18.2 Innoprot Business Overview
- 7.18.3 Innoprot Cell Activity Assay Service Revenue and Gross Margin (2021-2026)
- 7.18.4 Innoprot Cell Activity Assay Service Product Portfolio
- 7.18.5 Innoprot Recent Developments
- 7.19 Vela Labs GmbH
- 7.19.1 Vela Labs GmbH Company Information
- 7.19.2 Vela Labs GmbH Business Overview
- 7.19.3 Vela Labs GmbH Cell Activity Assay Service Revenue and Gross Margin (2021-2026)
- 7.19.4 Vela Labs GmbH Cell Activity Assay Service Product Portfolio
- 7.19.5 Vela Labs GmbH Recent Developments
- 7.20 Hanugen Theraputics
- 7.20.1 Hanugen Theraputics Company Information
- 7.20.2 Hanugen Theraputics Business Overview
- 7.20.3 Hanugen Theraputics Cell Activity Assay Service Revenue and Gross Margin (2021-2026)
- 7.20.4 Hanugen Theraputics Cell Activity Assay Service Product Portfolio
- 7.20.5 Hanugen Theraputics Recent Developments
8 North America
- 8.1 North America Cell Activity Assay Service Revenue (2021-2032)
- 8.2 North America Cell Activity Assay Service Revenue by Type (2021-2032)
- 8.2.1 North America Cell Activity Assay Service Revenue by Type (2021-2026)
- 8.2.2 North America Cell Activity Assay Service Revenue by Type (2027-2032)
- 8.3 North America Cell Activity Assay Service Revenue Share by Type (2021-2032)
- 8.4 North America Cell Activity Assay Service Revenue by Application (2021-2032)
- 8.4.1 North America Cell Activity Assay Service Revenue by Application (2021-2026)
- 8.4.2 North America Cell Activity Assay Service Revenue by Application (2027-2032)
- 8.5 North America Cell Activity Assay Service Revenue Share by Application (2021-2032)
- 8.6 North America Cell Activity Assay Service Revenue by Country
- 8.6.1 North America Cell Activity Assay Service Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Cell Activity Assay Service Revenue by Country (2021-2026)
- 8.6.3 North America Cell Activity Assay Service Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Cell Activity Assay Service Revenue (2021-2032)
- 9.2 Europe Cell Activity Assay Service Revenue by Type (2021-2032)
- 9.2.1 Europe Cell Activity Assay Service Revenue by Type (2021-2026)
- 9.2.2 Europe Cell Activity Assay Service Revenue by Type (2027-2032)
- 9.3 Europe Cell Activity Assay Service Revenue Share by Type (2021-2032)
- 9.4 Europe Cell Activity Assay Service Revenue by Application (2021-2032)
- 9.4.1 Europe Cell Activity Assay Service Revenue by Application (2021-2026)
- 9.4.2 Europe Cell Activity Assay Service Revenue by Application (2027-2032)
- 9.5 Europe Cell Activity Assay Service Revenue Share by Application (2021-2032)
- 9.6 Europe Cell Activity Assay Service Revenue by Country
- 9.6.1 Europe Cell Activity Assay Service Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Cell Activity Assay Service Revenue by Country (2021-2026)
- 9.6.3 Europe Cell Activity Assay Service Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Cell Activity Assay Service Revenue (2021-2032)
- 10.2 China Cell Activity Assay Service Revenue by Type (2021-2032)
- 10.2.1 China Cell Activity Assay Service Revenue by Type (2021-2026)
- 10.2.2 China Cell Activity Assay Service Revenue by Type (2027-2032)
- 10.3 China Cell Activity Assay Service Revenue Share by Type (2021-2032)
- 10.4 China Cell Activity Assay Service Revenue by Application (2021-2032)
- 10.4.1 China Cell Activity Assay Service Revenue by Application (2021-2026)
- 10.4.2 China Cell Activity Assay Service Revenue by Application (2027-2032)
- 10.5 China Cell Activity Assay Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Cell Activity Assay Service Revenue (2021-2032)
- 11.2 Asia Cell Activity Assay Service Revenue by Type (2021-2032)
- 11.2.1 Asia Cell Activity Assay Service Revenue by Type (2021-2026)
- 11.2.2 Asia Cell Activity Assay Service Revenue by Type (2027-2032)
- 11.3 Asia Cell Activity Assay Service Revenue Share by Type (2021-2032)
- 11.4 Asia Cell Activity Assay Service Revenue by Application (2021-2032)
- 11.4.1 Asia Cell Activity Assay Service Revenue by Application (2021-2026)
- 11.4.2 Asia Cell Activity Assay Service Revenue by Application (2027-2032)
- 11.5 Asia Cell Activity Assay Service Revenue Share by Application (2021-2032)
- 11.6 Asia Cell Activity Assay Service Revenue by Country
- 11.6.1 Asia Cell Activity Assay Service Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Cell Activity Assay Service Revenue by Country (2021-2026)
- 11.6.3 Asia Cell Activity Assay Service Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Cell Activity Assay Service Revenue (2021-2032)
- 12.2 SAMEA Cell Activity Assay Service Revenue by Type (2021-2032)
- 12.2.1 SAMEA Cell Activity Assay Service Revenue by Type (2021-2026)
- 12.2.2 SAMEA Cell Activity Assay Service Revenue by Type (2027-2032)
- 12.3 SAMEA Cell Activity Assay Service Revenue Share by Type (2021-2032)
- 12.4 SAMEA Cell Activity Assay Service Revenue by Application (2021-2032)
- 12.4.1 SAMEA Cell Activity Assay Service Revenue by Application (2021-2026)
- 12.4.2 SAMEA Cell Activity Assay Service Revenue by Application (2027-2032)
- 12.5 SAMEA Cell Activity Assay Service Revenue Share by Application (2021-2032)
- 12.6 SAMEA Cell Activity Assay Service Revenue by Country
- 12.6.1 SAMEA Cell Activity Assay Service Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Cell Activity Assay Service Revenue by Country (2021-2026)
- 12.6.3 SAMEA Cell Activity Assay Service Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst